Product ID: SQMIG35B2061
Report ID:
SQMIG35B2061 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
91 |
Figures:
76
The North American precision medicine market is expected to account for 44% of revenue share in 2022 because of the rising prevalence of cancer and genetic disorders, growing use of precision medicine approaches, and the presence of prominent companies such as Pfizer, Qiagen, Quest Diagnostics, and Roche. Cancer is the top cause of mortality in Canada and the second-highest cause of death in the US, according to the American Cancer Society. In the US, about 1.8 Billion new cancer cases will be diagnosed in 2020. High awareness of precision medicine in the region, as well as rising demand for tailored cancer therapy, will drive industry revenue in the region.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONGlobal Precision Medicine Software Market size was valued at USD 1.46 billion in 2019 and is poised to grow from USD 1.6 million in 2023 to USD 3.86 billion by 2031, growing at a CAGR of 11.4% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35B2061